{"id":"NCT00689481","sponsor":"Stiefel, a GSK Company","briefTitle":"Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies","officialTitle":"A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety and Efficacy of Emulsion Formulation U0267 , Versus Vehicle Foam in Subjects With Plaque-type Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-03","primaryCompletion":"2008-10","completion":"2008-10","firstPosted":"2008-06-03","resultsPosted":"2010-12-08","lastUpdate":"2016-10-07"},"enrollment":323,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DRUG","name":"U0267 Foam","otherNames":[]},{"type":"DRUG","name":"Vehicle foam","otherNames":[]}],"arms":[{"label":"U0267 foam","type":"EXPERIMENTAL"},{"label":"Vehicle foam","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to demonstrate the safety and efficacy of U0267 in subjects with plaque-type psoriasis.","primaryOutcome":{"measure":"Number of Subjects With Treatment Success, Assessed Per the Investigator's Static Global Assessment","timeFrame":"8 weeks","effectByArm":[{"arm":"Calcipotriene Foam","deltaMin":58,"sd":null},{"arm":"Vehicle Foam","deltaMin":17,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.016"},{"comp":"OG000 vs OG001","p":"0.843"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":9},"locations":{"siteCount":12,"countries":["United States"]},"refs":{"pmids":["22587791"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":214},"commonTop":[]}}